You just read:

Ending Neostigmine Methylsulfate Injection Shortages With BLOXIVERZ®, The Only FDA-Approved Neostigmine Methylsulfate Injection

News provided by

Eclat Pharmaceuticals

Apr 16, 2014, 10:02 ET